We are building the next enduring biotechnology company of the digital age.

 

Verge has pioneered the industry's most advanced all-in-human, artificial intelligence powered drug discovery platform to unlock new drugs at scale for the biggest medical challenges of our time.


 
Hero image.jpg

Our mission is to develop better drugs, faster using technology.

Verge was born from the convergence of multiple technological forces, including human genomics, machine learning, biological engineering, and translational medicine, that are enabling us to decipher biology. Instead of using animal or cell models, we have built one of the world's largest proprietary multi-omics databases directly from human tissue. We use machine learning to map the complex causes of disease and develop those insights into proprietary drug candidates on our internal biology and chemistry platforms.

In order to succeed in humans, we start in humans.

EXPLORE OUR APPROACH →

 
Home-our-mission-image.jpg
 

We are developing drugs to treat the biggest medical challenges of our generation.

Our first drug VRG50635, a small molecule inhibitor of PIKfyve, has entered the clinic for amyotrophic lateral sclerosis (ALS). It was discovered by CONVERGE®, Verge’s all-in-human, AI-powered platform, moving from research to clinic in just four years. We are working on a dozen breakthrough opportunities on Parkinson's Disease, Frontotemporal Dementia, and other devastating diseases with no effective treatments to date.

See our pipeline →

 
Home-developing-drugs-image.jpg

We are collaborating with industry leaders to transform drug discovery.

Partner with us →

 
Home-partner-image.jpg
 

We are a team of drug hunters, engineers, and neuroscientists united around an audacious vision.

Meet our Team →

 
Home-meet-team-image.jpg

We are pioneering a new type of culture in biotech.

Work WIth US →

 
Home-work-with-us-image.jpg